Key Insights

Highlights

Research Leaders

5 sponsors active, led by Norwegian Muscle Disease Association (FFM)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
Showing all 1 trials

Research Network

Active Sponsors

  • Norwegian Muscle Disease Association (FFM)1
  • University of Tromso1
  • University Hospital of North Norway1
  • Norwegian Competence Center for Sleep Disorders1
  • Norwegian National Adivisory Unit on Rare Disorders1

Top Investigators

Related Conditions

  • Limb Girdle Muscular Dystrophy Type 2i1
  • Limb Girdle Muscular Dystrophy1
  • Muscular Dystrophies1

Activity Timeline